Research Article
Microalbuminuria, Kidney Function, and Daily Physical Activity
Table 1
The demographic and clinical parameters of 139 patients.
| | Variable | |
| | Age (years) (mean ± SD) | | | Sex (male/female) (:) | 67/72 | | BMI (kg/m2) (mean ± SD) | | | Type 2 diabetes (present/absent) (:) | 57/82 | | Smoking (present/absent) (:) | 30/109 | | Presence of CAD (:) | 18/121 | | Use of ACE inhibitor (present/absent) (:) | 27/112 | | Use of calcium channel blocker (CCB) (present/absent) (:) | 27/112 | | Use of -blocker (present/absent) (:) | 25/114 | | Use of -blocker (present/absent) (:) | 4/135 | | Use of diuretic (present/absent) (:) | 21/118 | | Use of AT2 blocker (present/absent) (:) | 37/102 | | Use of spironolactone (present/absent) (:) | 8/131 | | Office systolic blood pressure (SBP) (mmHg) (mean ± SD) | | | Office DBP (mmHg) (mean ± SD) | |
|
|
SD: standard deviation; BMI: body mass index; CAD: coronary artery disease; ACE: angiotensin converting enzyme; CCB: calcium channel blocker; : beta-Adrenergic; : alpha-adrenergic; AT2: angiotensin receptor blocker; SBP: systolic blood pressure; DBP: diastolic blood pressure.
|
